logo

Biotech Stocks Facing FDA Decision In August 2019

Pending Drug Approvals
Pending Drug Approvals

After having had a banner year for new drug approvals in 2018, hitting a record number of 59, it looks like the pace of FDA approval is slowing down this year. Only 16 new drugs have been greenlighted so far this year compared to 26 during the same period last year.

Now, let's take a look at the companies that await a ruling from the FDA in August 2019.

Share



>